Now in private beta on Android — join the tester list.
Learn more
How Tabs works.
Log your health, spot your patterns, and share clear reports with your doctor.
The mechanism
From daily logs to doctor-ready reports.
Summaries and insights are generated with the help of Google's Gemini API. You review every insight before it goes anywhere — nothing is shared without you.
Privacy, in detail
The full story, no fine print.
Everything below comes straight from our privacy policy — the short version, in plain language.
What's collected
Your logs, notes, and documents you choose to upload.
Health data from Google Health Connect — heart rate, sleep, activity — only if you grant permission.
Location only to fetch weather context for your entries. We don't store your location history.
Where it lives
Your health data is synchronized and stored on our secure servers so it works across your devices and can power your insights. Data in transit is encrypted with TLS; on your phone, Android's Keystore protects local keys.
Who processes it
Google's Gemini API acts as our subprocessor to generate your summaries and insights. Processing follows Google's Gemini API terms — see the privacy policy for the details on data use.
How to delete everything
Delete your account in the app's Settings and your data is purged from our active databases. No app installed? Use the web deletion portal or email support — manual requests are processed within 48 hours.
What we will never claim: HIPAA certification, or that your data never leaves your device — it syncs to our servers and to Gemini, and we'd rather tell you that plainly. Read the full policy
For your doctor
Walk in with the summary they wish every patient brought.
What the report contains. An AI-written narrative — a user summary, symptom and biometric correlations, long-term physiological trends, a medication and intervention analysis, and a clinical summary for your doctor — plus data-availability counts and longitudinal health charts, one clean PDF per visit.
Protocol sync, explained. Upload your doctor's instructions once. Tabs tracks your daily data against your prescribed protocols and folds adherence into the report — so "are you following the plan?" has an actual answer.
Bring this to your appointment. Instead of trying to remember three months of symptoms in a fifteen-minute visit, hand over the summary and spend the time on decisions.
Report Range: Full Audit (180 Days) • Generated: Aug 9, 2026 - 08:29 PM
USER SUMMARY
Jordan Ellis is a 24-year-old male managing multiple chronic conditions, including a dysautonomia-related condition, a connective-tissue condition, a mast-cell–related condition, and a spinal curvature condition.
His current prescribed medication regimen includes Pulsecalm, Clarimood, Thymavine, and Kepvion, all taken daily as prescribed. He also self-reports taking a B-complex vitamin, Vitamin D3 (20 mcg (4,000 IU)), and Nervexa (50mg, 1½ twice a day).
He actively manages his conditions through physical therapy for rib and back pain related to his connective-tissue condition and spinal curvature, consistent use of compression garments (calf, socks, shorts, chest band), and a daily intake goal of three-quarters of a gallon of water and 4,500 mg of electrolytes with supplemental salt.
Regular follow-ups with Dr. Elena Marsh are scheduled monthly to adjust his lifestyle and medication plan.
SYMPTOM & BIOMETRIC CORRELATIONS
Heart Rate and Migraines: The user consistently reports migraines, often daily, and notes a specific trigger where migraines appear every time his heart rate exceeds 155 bpm. This correlation is a significant and recurring pattern in his self-reported symptoms.
Fatigue and Activity Levels: Periods of increased physical, mental, or social demands frequently correlate with heightened fatigue and energy crashes. For example, in late July, days noted as “Mentally demanding,” “Socially demanding,” or “Physically active” were often followed by reports of “Fatigue” (e.g., July 27, 26, 24, 23, 21, 19, 18, 17, 14). The user specifically noted on May 20 that a “holiday weekend” involving physical exertion led to “the worst I’ve felt,” with subsequent reports of body aches, brain fog, and extreme tiredness.
Rib Pain and Physical Therapy: Rib and back pain, attributed to his connective-tissue condition and spinal curvature, are frequently logged symptoms. The user noted on February 8 that his “back hurts after physical therapy,” indicating that therapeutic interventions, while necessary, can acutely exacerbate musculoskeletal discomfort. Pain in the left rib, sometimes described as “hurts to breathe,” is a persistent issue, appearing on numerous dates across the reporting period (e.g., July 1, June 29, 27, 24, 23, 22, 21, 20, 19, June 1, May 26, 25, 21, 16, May 8, 2, 1, April 25, 19, 17, 16, 15, April 9, March 31, March 5, February 27, 23, 20, 14, February 11, 7, 3).
Symptoms Consistent with His Autonomic Condition: Symptoms consistent with his dysautonomia-related condition, such as “seeing stars when standing” (August 3, June 29, April 28), “dizziness” (April 23), “light-headed” upon standing (April 10), and “blood pooling in feet” (June 17, June 10, May 9, March 14), are regularly reported. These often coincide with reports of heart palpitations, particularly upon positional changes (e.g., “rolling over in bed” on June 3, June 1, May 30, April 14, 12, or “sitting up” on May 30, March 4).
Sleep Disturbances and Mental Health: Sleep quality and duration are highly variable. The user frequently reports waking up tired, experiencing insomnia, or waking up multiple times during the night (e.g., August 7, February 21, 20, 18, February 10, 9, 8, 7, 4, 3, 2). On August 7, a “hard mental night” with “very vivid dreams” led to waking up “depressed and upset,” highlighting a direct link between sleep quality and mood.
Allergy and Immune System Indicators: Recent allergy testing in July 2026 showed negative results for common food allergens, but positive IgE reactions to several environmental allergens, including Bermuda Grass (Class I), Timothy Grass (Class II), Maple/Box Elder (Class 0/1), Mountain Cedar (Class 0/1), and Russian Thistle (Class 0). These findings may be relevant to his mast-cell–related condition symptoms. Additionally, June 2026 lab results indicated a blunted response to several pneumococcal vaccine types, suggesting possible immune system vulnerabilities.
LONG-TERM PHYSIOLOGICAL TRENDS
Heart Rate and HRV Stability: Over the 180-day period, the average heart rate was 68 bpm, with an average HRV (RMSSD) of 58.4 ms. While the average heart rate appears stable, the user’s self-reported heart rate instability, with episodes exceeding 155 bpm and even 195 bpm on minimal exertion, indicates significant autonomic dysregulation consistent with his dysautonomia-related condition.
Sleep Patterns: The average sleep duration was 6h 52m per night, with an average deep sleep of 1h 08m. Despite these averages, frequent logs indicate disturbed sleep, including difficulty falling asleep, early awakenings, and waking up tired, suggesting that the quality of sleep may be more problematic than the total duration.
Heart Rate Spikes: A total of 214 heart rate spikes were recorded over the period. The user’s observation that migraines appear when his heart rate goes over 155 bpm is a critical insight for managing his dysautonomia-related condition and migraine conditions.
Energy Levels and Pacing: The user frequently reports low energy, fatigue, and mental exhaustion, often after physically or mentally demanding activities. The “Pacing Budget” consistently shows a value of 8, while “PacePoints” vary, sometimes exceeding the budget significantly (e.g., 19.4 on July 23, 16.2 on July 21, 17.1 on July 18, 15.3 on July 17, 16.8 on July 16, 18.1 on July 14, 16.4 on July 13, 22.7 on July 6). This suggests challenges in consistently adhering to pacing guidelines, potentially contributing to symptom exacerbation and crashes.
Weight and BMI: With a height of 178.2 cm and a weight of 148.5 lbs, the user’s BMI is 21.2 kg/m2, which is within the healthy weight range. This was noted in the March 2026 cardiac imaging report.
Blood Pressure Trends: The average blood pressure across five readings was 117/76 mmHg. A specific reading on February 28, 2026, was 118/75 mmHg, and another on July 28, 2026, was 121/84 mmHg. These readings generally fall within a healthy range, though the diastolic pressure on July 28 is at the higher end of normal.
MEDICATION & INTERVENTION ANALYSIS
Pulsecalm Initiation: The user started taking Pulsecalm on April 9, 2026, as noted in his logs. In late April, he reported that “the pulsecalm is helping a little but it makes me tired.” This suggests a partial benefit in symptom management but with a notable side effect. His profile lists Pulsecalm as an active medication, taken daily.
Antidepressant Transition (Trenquix to Clarimood): The user’s logs indicate a switch from Trenquix to Clarimood. On July 25, 2026, he reported taking Trenquix 40mg and experiencing “stomach pain.” By July 28, 2026, he noted “we switched from Trenquix to clarimood because of the chest pain from before,” and subsequently logged taking Clarimood 40mg daily. This transition was made to address adverse effects, specifically chest pain, associated with Trenquix. He continued to report “chest pain still and a lot of hunger” on July 26, possibly as residual effects or new side effects of the antidepressant.
Peptide Therapy: Thymavine and Kepvion are listed as active medications in his profile and are consistently logged as taken daily from June 22, 2026, through August 5, 2026. No specific symptom changes are directly attributed to their initiation in the provided logs, but their consistent use indicates ongoing therapeutic intent.
Nervexa, B-Complex, and Vitamin D3: The user self-reports taking Nervexa, a B-complex vitamin, and Vitamin D3 daily. Lab results from May and July 2025 indicated low Vitamin D levels (22.7 ng/mL and 24.4 ng/mL, respectively), supporting the rationale for supplementation. B12 levels were within range (612 pg/mL) in July 2025.
Cefalora for Migraines: The user started taking Cefalora 50mg a day for migraines on February 19, 2026. No immediate impact on migraine frequency or intensity was explicitly logged following this initiation within the provided data.
Electrolyte and Water Intake: The user’s consistent effort to consume three-quarters of a gallon of water and 4,500 mg of electrolytes daily, including salt pills and hydration mixes, is a key behavioral intervention for his dysautonomia-related condition. Logs frequently mention “leg blood pooling” and “strong heart palpitations,” indicating that despite these efforts, symptoms of hypovolemia and dysautonomia persist.
Physical Therapy for Connective-Tissue/Spinal Issues: The user is actively engaged in physical therapy for pain in his ribs and back due to his connective-tissue condition and spinal curvature. Logs confirm that therapy can cause acute pain (e.g., “physical therapy made my back hurt and made it hard to sleep” on January 25, 2026), but this is part of the ongoing management strategy.
CLINICAL SUMMARY FOR YOUR DOCTOR
Improvements: The transition from Trenquix to Clarimood was initiated due to adverse effects, specifically chest pain, indicating a proactive approach to medication tolerability. Consistent adherence to Pulsecalm, Thymavine, and Kepvion, as well as electrolyte and hydration protocols, is evident. Food allergy testing was negative, ruling out common dietary triggers for his mast-cell–related condition, though environmental allergens were identified.
Areas of Concern: Daily migraines, often triggered by heart rates exceeding 155 bpm, remain a significant challenge. Persistent fatigue, low energy, and mental exhaustion, frequently exacerbated by activity, continue to impact daily functioning. Rib and back pain related to his connective-tissue condition and spinal curvature are ongoing, with physical therapy sometimes causing acute discomfort. Symptoms of his dysautonomia-related condition, including heart palpitations, dizziness, and blood pooling, are still prevalent despite current management strategies. Sleep quality is consistently poor, with frequent awakenings and reports of waking up tired, which also impacts mental well-being. Reduced pneumococcal antibody response suggests a potential immune deficiency that may warrant further investigation or targeted intervention.
Key Questions for Discussion:
Given the persistent migraines and their correlation with heart rate spikes, what further adjustments to Pulsecalm or other migraine prophylaxis could be considered?
How can the current pacing strategy be optimized to mitigate post-exertional malaise and energy crashes, particularly on days with higher physical, mental, or social demands?
What additional interventions or diagnostic workup could address the ongoing rib and back pain, especially considering the connective-tissue and spinal diagnoses?
Are there further strategies to improve sleep quality and address the associated mental health impacts, beyond the recent antidepressant switch?
Considering the reduced pneumococcal antibody response, is further immune evaluation or vaccination recommended?
What is the clinical significance of the low plasma histamine levels, especially in the context of his mast-cell–related condition, and does this suggest a need for adjustment in management?